In a move that has defied recommendations from health bodies, charities and doctors, the board of directors of tVectura Group have recommended shareholders accept Philip Morris International (PMI)’s 165 pence-per-share ($2.28 per-share) takeover offer for the company.
Previously, Carlyle Investment Management, the US private equity firm, had made a 155 pence-per-share offer for Wiltshire, UK-based Vectura, which specializes in inhaled drug delivery devices like asthma inhalers....
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?